Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Central Proteina Prima Tbk (CPRO)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
50 0    0.00%
26/04 - Closed. Currency in IDR ( Disclaimer )
Type:  Equity
Market:  Indonesia
ISIN:  ID1000105000 
  • Volume: 23,469,700
  • Bid/Ask: 50 / 51
  • Day's Range: 50 - 51
Central Proteina 50 0 0.00%

CPRO Income Statement

 
Featured here, the Income Statement (earnings report) for Central Proteina Prima Tbk, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Income Statement
Period Ending: 2023
31/12
2023
30/09
2023
30/06
2023
31/03
Total Revenue 2262638 2326692 2299791 2138155
Revenue 2262638 2326692 2299791 2138155
Other Revenue, Total - - - -
Cost of Revenue, Total 1855317 1870351 1869488 1753921
Gross Profit 407321 456341 430303 384234
Total Operating Expenses 2112541 2109332 2085230 1963602
Selling/General/Admin. Expenses, Total 217753 234260 217863 210745
Research & Development - - - -
Depreciation / Amortization 24615 24908 25016 24378
Interest Expense (Income) - Net Operating -54034 -50748 -45739 -47556
Unusual Expense (Income) - - - -
Other Operating Expenses, Total 68890 30561 18602 22114
Operating Income 150097 217360 214561 174553
Interest Income (Expense), Net Non-Operating - - - -
Gain (Loss) on Sale of Assets 41 56 2 -
Other, Net 66692 87401 62064 17752
Net Income Before Taxes 83364 129903 152495 156801
Provision for Income Taxes 3253 35790 40226 41520
Net Income After Taxes 80111 94113 112269 115281
Minority Interest 3024 2961 2917 2835
Equity In Affiliates - - - -
U.S GAAP Adjustment - - - -
Net Income Before Extraordinary Items 80036 94064 112187 115181
Total Extraordinary Items - - - -
Net Income 80036 94064 112187 115181
Total Adjustments to Net Income - - - -
Income Available to Common Excluding Extraordinary Items 80036 94064 112187 115181
Dilution Adjustment - - - -
Diluted Net Income 80036 94064 112187 115181
Diluted Weighted Average Shares 59572.38 59572.38 59572.38 59572.38
Diluted EPS Excluding Extraordinary Items 1.34 1.58 1.88 1.93
DPS - Common Stock Primary Issue - - - -
Diluted Normalized EPS 1.03 1.37 1.63 1.64
* In Millions of IDR (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the income statement, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

CPRO Comments

Write your thoughts about Central Proteina Prima Tbk
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email